Thirteenth Biannual Report of the Cochrane Haematological Malignancies Group--Focus on Multiple Myeloma
Authors:
- Kathrin BauerKBKathrin Bauer
- Michaela RanceaMRMichaela Rancea
- Bettina SchmidtkeBSBettina Schmidtke
- Sabine KlugeSKSabine Kluge
- Ina MonsefIMIna Monsef
- Kai HübelKHKai Hübel
- Andreas EngertAEAndreas Engert
- Nicole SkoetzNSNicole Skoetz
Open Access
- 20 July 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 103 (17) , E1-E19
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Multiple MyelomaNew England Journal of Medicine, 2011
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)Blood, 2010
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialThe Lancet, 2010
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialThe Lancet, 2010
- Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trialThe Lancet Oncology, 2010
- International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantationLeukemia, 2009
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple MyelomaNew England Journal of Medicine, 2008
- Transfusion independence in patients with myelodysplastic syndromesCancer, 2006
- Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trialThe Lancet, 2006